QuidelOrtho to invest 750K in heart disease awareness

LabPulse.com staff writers
Jun 21, 2022
2019 07 03 22 37 5166 Heart 400

QuidelOrtho on Monday announced that its subsidiary, Quidel, will invest funding totaling $750,000 and support over the next three years in American Heart Association (AHA) initiatives to promote cardiovascular and brain health, prevent heart disease and stroke, and support research.

As part of the collaboration, Quidel will invest the funding and give support for campaigns and initiatives led by the AHA's San Diego division.

"As we remain dedicated to addressing unmet needs in diseases, our top priority continues to be to elevate attention to heart disease," Douglas Bryant, chairman and CEO of QuidelOrtho, said in a statement.

Latest in Heart Disease
Cardiac Heart Eeg Social
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
December 6, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Cigarette Smoking Social
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
September 29, 2023
Cardiac Heart Eeg Social
Can a simple saliva test ID CVD risk?
August 24, 2023
Related Stories
Heart Damage Social
Heart Disease
ApoB testing may reveal patients at risk of heart disease missed by cholesterol tests: study
Business Graph Money Stocks
Financial Results
QuidelOrtho expects Q3 revenues of $782 million to $785 million
2022 06 09 18 00 5852 Lab Blood Samples 400
Pulmonary Arterial Hypertension
Elevated cfDNA levels linked to severity of PAH
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Heart Disease
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
By Matt Limb
A high-sensitivity blood test can improve diagnosis for 1 in 5 patients who have a heart muscle injury, according to a U.K. hospital study.
December 6, 2023
Cardiac Heart Eeg Social
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
By Matt Limb
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
Molecule Social
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
By Nick Paul Taylor
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
Cigarette Smoking Social
Can a simple saliva test ID CVD risk?
By Melissa Busch
Researchers in Canada say that the early warning signs of cardiovascular disease may be gleaned from a simple saliva sample.
August 24, 2023
Cardiac Heart Eeg Social
Inflammation marker MPO linked with mortality risk: Study
By LabPulse.com staff writers
MPO, a marker of chronic inflammation, has been linked with mortality from cardiovascular disease; this study is the first to show an association of MPO with mortality from other diseases.
August 3, 2023
Heart Artificial Intelligence Ai Social
Analysis of 462M lipid test results reveals global variation in cholesterol levels
By Nick Paul Taylor
Mean total cholesterol levels exceeded the World Health Organization (WHO) target in seven of the 17 countries included in the analysis, namely Japan, Australia, North Macedonia, Switzerland, Germany, Slovakia, and Austria.
July 17, 2023
Globe Flags Social
Heart injury biomarker may help COVID-19 patients avoid hospitalization
By Elissa Wolfson
Researchers found that measuring blood levels of cardiac troponin, a heart injury biomarker, may help COVID-19 patients avoid hospitalization.
April 25, 2023
Heart Attack Disease 3 D Social
RNA biomarkers may help confirm heart disease, study finds
By Elissa Wolfson
RNA analysis of blood from patients with angiographically confirmed coronary artery disease demonstrates how RNA biomarkers may help confirm heart disease.
March 30, 2023
Heart Attack Disease 3 D Social
ApoB testing may reveal patients at risk of heart disease missed by cholesterol tests: study
By Nick Paul Taylor
In the study, investigators looked at electronic medical records for patients who had ApoB and standard lipid profiles tested within 90 days of each other from 2010 to early 2022.
March 6, 2023
Heart Damage Social
‘Good’ cholesterol worse for some adults: NIH study
By Jared Berberabe
In the study, lower levels of "good" cholesterol were associated with increased risks for heart attacks for white but not Black adults.
November 23, 2022
Heart Artificial Intelligence Ai Social
Physician, medical office to pay more than $2.6M involving clinical lab kickbacks
By LabPulse.com staff writers
Feel Well Health and its owner violated the Anti-Kickback Statute by receiving remuneration from Boston Heart Diagnostics for clinical laboratory services for Medicare patients, according to the DOJ.
November 15, 2022
Gavel Money Social
UK Biobank study links COVID-19 infection with poor cardiovascular health
By Jared Berberabe
Individuals who have been hospitalized because of COVID-19 infection have a higher risk of experiencing adverse cardiovascular health outcomes, according to a UK Biobank study.
October 27, 2022
Heart Damage
Page 1 of 2
Next Page